Atrial Fibrillation is Associated with Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR: Insights From the PARTNER 2A and PARTNER 2 S3i Trials Biviano, A., Nazif, T., Dizon, J., Garan, H., Crowley, A., Malaisrie, S., Makkar, R., Thourani, V., Mack, M., Szeto, W. Y., Fearon, W., Leon, M., Kodali, S. ELSEVIER SCIENCE INC. 2017: B46–B47

View details for Web of Science ID 000413459200107